Clinical trials: Gastrointestinal Neoplasm Malignant
Colon Neoplasm, Pain
Comparing Water Immersion and Water Exchange Methods During Minimally Sedated Colonoscopy
In minimally sedated Asian patients in a community setting the investigators showed that a limited volume of water infusion instead of air insufflation in either the rectal sigmoid colon or the whole colon significantly reduced…
- Trial name
- NCT01535326
- Testing
- air insufflation, water immersion, water exchange
- Where
- Taiwan
- Volunteers
- 270 people
- Sponsor
- Dalin Tzu Chi General Hospital
Cancer, Thoracic Neoplasms
Improving Cancer On-treatment Symptom Management
Patient-reported outcome measures (PROMs) is an umbrella term that refers to any report on a health status measure that is reported directly by the patient, without the influence of clinicians or anyone else.
- Conditions
- Cancer, Thoracic Neoplasms, Gastrointestinal Cancer, Lung Cancer
- Trial name
- IMPROVE (NCT04589247)
- Where
- 4 sites in United States
- Volunteers
- 104 people
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Pancreatic Mucinous-Cystic Neoplasm
Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms
This study will evaluate intracystic NanoPac® (Sterile Nanoparticulate Paclitaxel) administered via endoscopic ultrasound-guided fine needle injection (EUS-FNI) in subjects with mucinous cystic pancreatic neoplasms.
- Trial name
- NCT03188991
- Testing
- NanoPac®
- Where
- 4 sites in United States
- Volunteers
- 20 people
- Sponsor
- NanOlogy, LLC
Refractory Metastatic Colorectal Cancer
A Study Evaluating TAS-102 Plus Nivolumab in Patients With MSS CRC
A Phase 2 Study with Safety Lead-in, Evaluating TAS-102 Plus Nivolumab in Participants with Microsatellite Stable Refractory Metastatic Colorectal Cancer
- Trial name
- NCT02860546
- Testing
- TAS-102, nivolumab
- Where
- 3 sites in United States
- Volunteers
- 18 people
- Sponsor
- Taiho Oncology, Inc.